Temgesic 0,4 mg, Sublingualtabletten - 10 Tablette(n) Swissmedic Key 44100037 Registration Holder Eumedica Pharmaceuticals AG Name Temgesic 0,4 mg, Sublingualtabletten Date of registration 01.03.1983 Introduction of Sequence 26.09.1991 ATC-Classification Buprenorphine (N02AE01) Revision date 05.10.2007 WHO WHO-DDD Valid until Index Therapeuticus (BSV) 01.01.30. Show package size 10 Tablette(n) Index Therapeuticus (Swissmedic) 01.01.30. Description Swissmedic categorie. A+ SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 8.10 Limitation No Deductible 10 % Consumer price 25.25 Feedback FB Daily cost GTIN 7680441000376 Medication Code SynthetikaA Pharmacode 1438945 Disponibility
Composition buprenorphinum 0.4 mg ut buprenorphini hydrochloridum, lactosum monohydricum corresp. lactosum 28.144 mg, mannitolum, maydis amylum, povidonum K 30, acidum citricum, natrii citras dihydricus corresp. natrium 0.036 mg, magnesii stearas, pro compresso. Packungsbestandteile Galenic Form Sublingual tablets Active Agent Dose Buprenorphine 0.4 mg
BAG: Active Agent Dose Buprenorphine 0.4 mg
Inactive agents Dose Citric Acid Lactose Monohydrate Magnesii Stearas Mannitol Maydis Amylum Natrii Citras Dihydricus Povidonum K 30 Pro Compresso
Source Data was imported : 14.04.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
